No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antineoplastic Agents, Immunological / adverse effects*
-
Carcinoma, Transitional Cell / drug therapy*
-
Drug Eruptions / etiology*
-
Humans
-
Lymphatic Metastasis
-
Skin / drug effects*
-
Skin / pathology
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / secondary
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents, Immunological
-
enfortumab vedotin